We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $604M
1-Year Est. Return 96.57%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$415M
AUM Growth
+$44.4M
Cap. Flow
+$2.96M
Cap. Flow %
0.71%
Top 10 Hldgs %
45.62%
Holding
96
New
27
Increased
21
Reduced
16
Closed
26

Top Buys

Rank Stock Value
1
WCG
Wellcare Health Plans, Inc.
WCG
+$11.3M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$10.7M
3
LJPC
La Jolla Pharmaceutical Company
LJPC
+$9.88M
4
BEAT
BioTelemetry, Inc.
BEAT
+$8.09M
5
ELV icon
Elevance Health
ELV
+$8.01M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$18.6M
2
GILD icon
Gilead Sciences
GILD
+$16M
3
CVS icon
CVS Health
CVS
+$13.6M
4
ASND icon
Ascendis Pharma A/S
ASND
+$10.6M
5
NVO
Novo Nordisk
NVO
+$8.47M

Sector Composition

Rank Sector Weight
1 Healthcare 76.72%
2 Miscellaneous 22.27%
3 Technology 1.01%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACAD icon
1
PUT
Acadia Pharmaceuticals
ACAD
$5.02B
$54.9M 13.25%
+2,055,700
New +$52.5M
GWPH
2
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$21.4M 5.16%
124,164
+61,978
+100% +$10.7M
HCA icon
3
HCA Healthcare
HCA
$90.5B
$21.2M 5.12%
157,184
+49,756
+46% +$6.29M
WCG
4
DELISTED
Wellcare Health Plans, Inc.
WCG
$17.8M 4.3%
62,495
+41,036
+191% +$11.3M
GSK icon
5
GSK
GSK
$102B
$15.2M 3.66%
303,600
+94,000
+45% +$4.72M
MRTX
6
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$13.9M 3.36%
135,300
+78,500
+138% +$6.11M
MEDP icon
7
Medpace
MEDP
$16.8B
$12.2M 2.93%
185,815
+3,949
+2% +$228K
LJPC
8
DELISTED
La Jolla Pharmaceutical Company
LJPC
$12.1M 2.92%
+1,310,367
New +$9.88M
ALNY icon
9
Alnylam Pharmaceuticals
ALNY
$31.7B
$11M 2.65%
151,553
+72,400
+91% +$5.55M
MDT icon
10
Medtronic
MDT
$117B
$9.39M 2.27%
96,464
-35,000
-27% -$3.2M
ALXN
11
DELISTED
Alexion Pharmaceuticals
ALXN
$9.37M 2.26%
71,521
+36,100
+102% +$4.65M
MRK icon
12
PUT
Merck
MRK
$366B
$8.38M 2.02%
+104,800
New +$8.02M
NVS icon
13
Novartis
NVS
$292B
$8.3M 2%
+90,870
New +$7.69M
DRNA
14
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$8.29M 2%
526,059
-240,921
-31% -$3.28M
ELV icon
15
Elevance Health
ELV
$85.5B
$8.28M 2%
+29,339
New +$8.01M
CERN
16
PUT
DELISTED
Cerner Corp
CERN
$7.99M 1.93%
+109,000
New +$7.35M
ITCI
17
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$7.89M 1.9%
+607,800
New +$7.8M
HUM icon
18
Humana
HUM
$46.3B
$7.51M 1.81%
28,307
+17,490
+162% +$4.44M
BEAT
19
DELISTED
BioTelemetry, Inc.
BEAT
$7.41M 1.79%
+153,955
New +$8.09M
UNH icon
20
UnitedHealth
UNH
$353B
$7.12M 1.72%
29,176
+13,769
+89% +$3.31M
UTHR icon
21
United Therapeutics
UTHR
$22.1B
$6.47M 1.56%
82,892
+49,237
+146% +$4.6M
SYNH
22
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$6.43M 1.55%
125,899
+44,000
+54% +$2.05M
VKTX icon
23
Viking Therapeutics
VKTX
$3.75B
$6.26M 1.51%
754,759
-97,401
-11% -$832K
CVS icon
24
CVS Health
CVS
$119B
$6.2M 1.49%
113,738
-253,333
-69% -$13.6M
RVNC
25
DELISTED
Revance Therapeutics, Inc.
RVNC
$5.24M 1.26%
403,664
+149,083
+59% +$1.88M
1
2 3 4

Similar funds

EFL
ERn Financial LLC Middleton, Wisconsin $604M AUM 19.83% 1-Year Est. Return
V
VeraBank Henderson, Texas $604M AUM 23.32% 1-Year Est. Return
MAM
Morse Asset Management Darien, Connecticut $604M AUM 72.61% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
AMG
Advisors Management Group La Crosse, Wisconsin $604M AUM 64.38% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $605M AUM
VCP
Varenne Capital Partners Paris, France $603M AUM 46.34% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Sio Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Sio Capital Management held 96 positions worth $415M, up 12% from $370M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Sio Capital Management's Q2 2019 filing shows 27 new, 21 increased, 16 reduced and 26 closed positions. Its largest new stake was La Jolla Pharmaceutical Company: 1,310,367 shares worth $12.1M. The largest sale was Biogen, an estimated $18.6M.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, down from 87% a quarter earlier, followed by Miscellaneous and Technology.

  • Sio Capital Management's largest Q2 2019 buy was La Jolla Pharmaceutical Company: 1,310,367 shares worth $12.1M.
  • Sio Capital Management added most to Wellcare Health Plans, Inc. in Q2 2019, an estimated $11.3M increase.
  • Sio Capital Management's biggest Q2 2019 reduction was CVS Health, cutting an estimated $13.6M.
  • Sio Capital Management fully exited Biogen in Q2 2019, selling an estimated $18.6M.
  • Sio Capital Management's ten largest holdings make up 46% of its $415M portfolio in Q2 2019.
  • Sio Capital Management opened 27 new positions and closed 26 in Q2 2019.
  • Sio Capital Management's portfolio value rose 12% quarter-over-quarter to $415M.

Based on Sio Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.